These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1611604)

  • 1. Treatment for radiation-induced xerostomia. An innovative remedy.
    Kusler DL; Rambur BA
    Cancer Nurs; 1992 Jun; 15(3):191-5. PubMed ID: 1611604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
    Ngeow WC; Chai WL; Rahman RA; Ramli R
    Singapore Dent J; 2006 Dec; 28(1):1-3. PubMed ID: 17378333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral complications of cancer therapies. Management of salivary dysfunction.
    Greenspan D
    NCI Monogr; 1990; (9):159-61. PubMed ID: 2342589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilocarpine in the prevention of postirradiation xerostomia.
    Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
    Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced xerostomia: how dry is your patient?
    Bruce SD
    Clin J Oncol Nurs; 2004 Feb; 8(1):61-7. PubMed ID: 14983765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH; Hodgson TA; Ship JA; Schiødt M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention and treatment of radiotherapy - induced xerostomia.
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
    Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
    J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
    de Castro G; Federico MH
    Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and management of radiation-induced xerostomia.
    Berk LB; Shivnani AT; Small W
    J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing radiation induced xerostomia.
    Koukourakis MI; Danielidis V
    Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
    Wijers OB; Levendag PC; Braaksma MM; Boonzaaijer M; Visch LL; Schmitz PI
    Head Neck; 2002 Aug; 24(8):737-47. PubMed ID: 12203798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
    Jha N; Seikaly H; Harris J; Williams D; Sultanem K; Hier M; Ghosh S; Black M; Butler J; Sutherland D; Kerr P; Barnaby P
    Head Neck; 2009 Feb; 31(2):234-43. PubMed ID: 19107948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia.
    Davies AN; Singer J
    J Laryngol Otol; 1994 Aug; 108(8):663-5. PubMed ID: 7930915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.